ProKidney
PROK
18 hedge funds and large institutions have $144M invested in ProKidney in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 60 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
23% less capital invested
Capital invested by funds: $187M → $144M (-$42.5M)
48.87% less ownership
Funds ownership: 74.91% → 26.04% (-49%)
73% less funds holding
Funds holding: 67 → 18 (-49)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
80% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 60
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$90.1M |
| 2 |
SCM
Suvretta Capital Management
New York
|
+$27.8M |
| 3 |
BL
Bleichroeder LP
New York
|
+$17.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.32M |
| 5 |
BlackRock
New York
|
+$947K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$17.4M |
| 2 |
Millennium Management
New York
|
-$14.8M |
| 3 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
-$11.7M |
| 4 |
SC
Sculptor Capital
New York
|
-$11.1M |
| 5 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
-$8.38M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PCM
76
PenderFund Capital Management
Vancouver,
British Columbia, Canada
| – | -$91K | -7,094 | Closed |
|
77
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$34K | -3,454 | Closed |
|
|
PCM
78
Penserra Capital Management
Orinda,
California
| – | -$26K | -2,704 | Closed |
|
PROK Hedge Fund Activity: Q3 2022 in Review
18 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q3 2022, worth a combined $144M — down 23% from $187M a quarter earlier.
Sellers outnumbered buyers: 60 funds closed out of PROK and 12 opened new positions — a net loss of 48 holders — while 4 trimmed existing stakes and 1 added.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $90.1M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $17.4M sold.
- 18 institutional investors held ProKidney (PROK) as of Q3 2022, down from 67 in Q2 2022.
- Funds reported $144M of ProKidney stock for Q3 2022, down 23% quarter-over-quarter.
- 12 funds opened new ProKidney positions in Q3 2022 and 60 closed out, a net change of -48 holders.
- The largest ProKidney buyer in Q3 2022 was Morgan Stanley, an estimated $90.1M added.
- The largest ProKidney seller in Q3 2022 was Adage Capital Partners, an estimated $17.4M sold.
Based on aggregated 13F filings for Q3 2022.